Mate Health adds urologist and OB-GYN to medical advisory board

Mate Health has named Nicholas Farber, MD, and Tashera Perry, MD, to its Medical Advisory Board as the Chicago-based company pushes earlier male fertility testing. The appointments bring urology and OB-GYN expertise together around at-home semen analysis and reporting aimed at helping couples assess fertility sooner.

Why it matters: - Male factors contribute to about 50% of infertility cases, but male evaluation is often delayed or skipped. - Mate Health is positioning at-home testing as a way to make male fertility assessment easier to start and complete. - The new advisory board members add specialty input on how fertility results are presented to both patients and clinicians.

What happened: - Mate Health announced the appointments of Nicholas Farber, MD, and Tashera Perry, MD, to its Medical Advisory Board. - The company is based in Chicago and focuses on clinical-grade at-home male fertility testing. - The advisory board now includes both urology and OB-GYN perspectives.

The details: - Mate Health's testing uses at-home specimen collection with analysis performed in a CLIA-certified, CAP-accredited, high-complexity andrology laboratory. - The company says its methodology aligns with the World Health Organization laboratory manual, 6th Edition. - Mate Health says at-home collection removes the need for an in-clinic collection visit. - Dr. Farber advises Mate Health on clinical reporting and communication, including how advanced measures such as sperm DNA fragmentation are presented. - Dr. Perry advises on reproductive health and fertility diagnostics, with attention to how results are communicated to patients and the clinicians managing their care. - The company says the advisory board helps make reports useful across urology and OB-GYN practices. - Mate Health's tests report core semen parameters along with advanced measures including sperm DNA fragmentation and vitality. - The company's kit uses validated Active Cooling transport to preserve specimen integrity in transit. - More information is available at Mate Health's website.

Between the lines: - The appointments reflect a push toward a couple-centric fertility model rather than treating female evaluation as the default starting point. - Dr. Farber and Dr. Perry bring credibility in two specialties that often intersect early in fertility workups. - The emphasis on reporting format suggests Mate Health is trying to fit into existing clinical workflows, not just serve direct-to-consumer demand.

What's next: - Mate Health is likely to lean on the new advisory board as it refines testing reports and clinician-facing communication. - The company may continue building its position around earlier male testing and easier access for patients who would otherwise delay evaluation. - Dr. Perry's focus on rural access and digital workflows points to broader use cases beyond urban fertility centers.

The bottom line: - Mate Health is expanding its medical advisory bench to support a broader push for earlier, easier male fertility testing within couple-based fertility care.